Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
McKesson
Boehringer Ingelheim
Express Scripts
Merck

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca Pharmaceuticals LP v. Amneal Pharmaceuticals LLC (D. Del. 2015)

See Plans and Pricing

« Back to Dashboard

AstraZeneca Pharmaceuticals LP v. Amneal Pharmaceuticals LLC (D. Del. 2015)

Docket   Start Trial Date Filed 2015-12-09
Court District Court, D. Delaware Date Terminated
Cause 35:145 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties AMNEAL PHARMACEUTICALS CO. INDIA PRIVATE LIMITED; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK, LLC; AMYLIN PHARMACEUTICALS, LLC; ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP
Patents 5,424,286; 6,858,576; 6,872,700; 6,902,744; 6,956,026; 7,297,761; 7,521,423; 7,741,269
Attorneys Benjamin A. Smyth; Daniel M. Silver; John C. Phillips , Jr.; Michael P. Kelly
Link to Docket External link to docket
Small Molecule Drugs cited in AstraZeneca Pharmaceuticals LP v. Amneal Pharmaceuticals LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AstraZeneca Pharmaceuticals LP v. Amneal Pharmaceuticals LLC (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-12-09 1 following patents are listed in the FDA’s Orange Book Byetta®: U.S. Patent Nos. 5,424,286, 6,858,576…expiration of U.S. Patent Nos. 6,872,700 (the “’700 patent”) and 6,902,744 (the “’744 patent”). …infringement of the ’700 patent and the ’744 patent (collectively, “the asserted patents”). This Court has … This action is for patent infringement, brought pursuant to the patent laws of the United States… This civil action for patent infringement arises under the patent laws of the United States, including External link to document
2015-12-09 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,872,700; 6,902,744;. (sar) … 9 December 2015 1:15-cv-01139 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Dow
Moodys
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.